Effect of 0.01% Atropine on diopter and optic axis in adolescents and children with myopia
Related Experiment Video
Updated: Aug 6, 2025

Inducement and Evaluation of a Murine Model of Experimental Myopia
Published on: January 22, 2019
Liping Xia1, Hongwei Zhao1, Yuan Wang1
1Department of Ophthalmology, Special Medical Center of Strategic Support Force, Beijing, China.
Abstract:
The purpose of this study was to investigate the effect of 0.01% Atropine eye drops on diopter and optic axis in adolescents and children with myopia. A total of 164 children with myopia were randomly divided into two groups, Group A and Group B with 82 patients in each group, according to the digital table method. Group A was treated with 0.01% Atropine eye drops, while Group B was treated with single vision lenses. Before the treatment, there was no significant difference in diopter and axial length between the two groups (P=0.624 and P=0.123). After 12 months of treatment, the diopter and axial length of Group A were lower than those of Group B (P < 0.001 and P = 0.005). There were no obvious adverse reactions during corrective therapy in the two groups. The results show that compared with single vision lenses, 0.01% Atropine is more effective in correcting myopia, and may control the increase of optic axis in adolescents and children with myopia, in a better way, with high safety..
More Related Videos
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Properties of Enantiomers and Optical Activity
Glaucoma: Overview
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Focusing of Light in the Eye

